Welcome to clonexpress.com
.
.
Technology:
Patient-Specific cells: Beta Cells, Dopaminergic neuron, Hepatocytes
Clonexpress has developed a novel technology platform to obtain patient-specific
differentiated cell types from human primary fibroblasts and peripheral blood
mononuclear cells (PBMNC) by epigenetic induction. PBMNC and fibroblasts are
directly converted to a homogeneous population of a specific cell type, such as
hepatocytes, pancreatic beta cells, dopaminergic neurons etc.
Technology
Cell Lines available for evaluation and licencing:
Additional cell lines are under different stages of development.
Clonexpress also provides human CNS primary cells for in vitro research.
Patient-Specific cells: Beta Cells, Dopaminergic neuron, Hepatocytes
Clonexpress has developed a novel technology platform to obtain patient-specific
differentiated cell types from human primary fibroblasts and peripheral blood
mononuclear cells (PBMNC) by epigenetic induction. PBMNC and fibroblasts are
directly converted to a homogeneous population of a specific cell type, such as
hepatocytes, pancreatic beta cells, dopaminergic neurons etc.
Technology
Cell Lines available for evaluation and licencing:
 | Human fetal and adult pancreatic beta cell | |
| Human dopaminergic neuron | |
| Human neuronal progenitor cell | |
| Human astrocytes | |
| Human aotic endothelial cell | |
| Human hepatocytes |
Clonexpress also provides human CNS primary cells for in vitro research.
| Astrocytes HAST | |
| Dopaminergic neuron cells DAN Cells | |
| Microglial cells HMG | |
| Neuronal progenitor cells HNPC | |
CLONEXPRESS
Innovations in Cell Based Therapy and Drug Discovery
Innovations in Cell Based Therapy and Drug Discovery
 | |  | |  | |  |